These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32005977)

  • 1. WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway.
    Li Y; Zhou Y; Li B; Chen F; Shen W; Lu Y; Zhong C; Zhang C; Xie H; Katanaev VL; Jia L
    Oncogene; 2020 Mar; 39(13):2741-2755. PubMed ID: 32005977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WDR74 induces nuclear β-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis.
    Li Y; Chen F; Shen W; Li B; Xiang R; Qu L; Zhang C; Li G; Xie H; Katanaev VL; Jia L
    Cancer Lett; 2020 Feb; 471():103-115. PubMed ID: 31838084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZBTB7A interferes with the RPL5-P53 feedback loop and reduces endoplasmic reticulum stress-induced apoptosis of pancreatic cancer cells.
    Tang J; Chen L; Chang Y; Hang D; Chen G; Wang Y; Feng L; Xu M
    Mol Carcinog; 2024 Sep; 63(9):1783-1799. PubMed ID: 38896079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
    Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
    Elife; 2018 Mar; 7():. PubMed ID: 29547122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibitory effects of large subunit ribosomal proteins in melanoma.
    Kardos GR; Dai MS; Robertson GP
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):801-12. PubMed ID: 24807543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis.
    Xiong X; Zhao Y; Tang F; Wei D; Thomas D; Wang X; Liu Y; Zheng P; Sun Y
    Elife; 2014 Aug; 3():e02236. PubMed ID: 25144937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Worrall C; Suleymanova N; Crudden C; Trocoli Drakensjö I; Candrea E; Nedelcu D; Takahashi SI; Girnita L; Girnita A
    Oncogene; 2017 Jun; 36(23):3274-3286. PubMed ID: 28092675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
    Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
    Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.
    Koma YI; Ito A; Watabe K; Kimura SH; Kitamura Y
    Histol Histopathol; 2004 Apr; 19(2):391-400. PubMed ID: 15024700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
    Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
    Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
    Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
    Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.
    Chen D; Zhang Z; Li M; Wang W; Li Y; Rayburn ER; Hill DL; Wang H; Zhang R
    Oncogene; 2007 Aug; 26(35):5029-37. PubMed ID: 17310983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma.
    Patel A; Garcia LF; Mannella V; Gammon L; Borg TM; Maffucci T; Scatolini M; Chiorino G; Vergani E; Rodolfo M; Maurichi A; Posch C; Matin RN; Harwood CA; Bergamaschi D
    Cancer Res; 2020 Jun; 80(12):2676-2688. PubMed ID: 32291316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.
    Boudreault J; Canaff L; Ghozlan M; Wang N; Guarnieri V; Salcuni AS; Scillitani A; Goltzman D; Ali S; Lebrun JJ
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.